Company: ARMP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077648
Chunk: 28

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 28
---
                  
 any additional indebtedness, issuing additional securities, or entering into a merger, consolidation or sale of our business; |

| · | a discussion of any material or special United                              
 States federal income tax considerations applicable to the debt securities; |

| · | information describing any book-entry features; |

| · | provisions for a sinking fund purchase or other 
 analogous fund, if any;                         |

| · | any provisions for payment of additional amounts                                                                     
 for taxes and any provision for redemption, if we must pay such additional amount with respect to any debt security; |

<div align='center'>18</div>

| · | whether the debt securities are to be offered                                                                         
 at a price such that they will be deemed to be offered at an “original issue discount” as defined in paragraph (a) of 
 Section 1273 of the Internal Revenue Code;                                                                            |

| · | the denominations in which we will issue the                                                        
 series of debt securities, if other than denominations of $1,000 and any integral multiple thereof; |

| · | the terms on which a series of debt securities                                                                                        
 may be convertible into or exchangeable for our common stock, any other of our securities or securities of a third party, and whether 
 conversion or exchange is mandatory, at the option of the holder or at our option;                                                    |

| · | events of default; |

| · | whether we and/or the debenture trustee may change 
 an indenture without the consent of any holders;   |

| · | the form of debt security and how it may be exchanged 
 and transferred;                                      |

| · | descriptions of the debenture trustee and paying 
 agent, and the method of payments; and           |

| · | any other specific terms, preferences, rights                                                                                             
 or limitations of, or restrictions on, the debt securities, including any additional events of default or covenants provided with respect 
 to the debt securities, and any terms which may be required by us or advisable under applicable laws or regulations.                      |

Specific indentures will contain
additional important terms and provisions and will be incorporated by reference as an exhibit to the registration statement that includes
this prospectus, or as an exhibit to a report filed under the Exchange Act, incorporated by reference in this prospectus.

<div align='center'>19

DESCRIPTION OF WARRANTS</div>

We may issue warrants for
the purchase of common stock or preferred stock, in one or more series. We may issue warrants independently or together with common stock,